Press Release / Health and Fitness / Bioinformatics Market worth 16.18 Billion USD by 2021

Bioinformatics Market worth 16.18 Billion USD by 2021

Bioinformatics Market worth 16.18 Billion USD by 2021

Growing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, growing application of bioinformatics, and improved collaborative ties between companies and research institutes are the major factors driving the growth of the bioinformatics market. On the other hand, lack of well-defined standards and common data formats for integration of data, shortage of skilled bioinformatics professionals, and lack of adequate user-friendly tools are the major factors restraining the growth of this market.
Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2021
Browse 136 market data tables and 47 figures spread through 184 pages and in-depth TOC on “Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2021”
https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html
Early buyers will receive 10% customization on reports.
The bioinformatics market is segmented on the basis of sector, products and services, application, and region. Based on sector, the bioinformatics market is categorized into medical biotechnology, academics, animal biotechnology, agricultural technology, environmental biotechnology, forensic biotechnology, and other sectors (homeland security and defense, law enforcement groups, bioweapon creation, and evolutionary biotechnology). In 2016, the medical biotechnology segment is expected to account for the largest share of the bioinformatics market. This is attributed to the increasing use of bioinformatics in drug discovery and development processes for the faster development of safe and effective drugs at reduced costs.
On the basis of products and services, the bioinformatics market is categorized into knowledge management tools, bioinformatics platforms, and bioinformatics services. The knowledge management tools segment is expected to account for the largest market share in 2016. However, the bioinformatics platforms segment is expected to grow at the highest CAGR during the forecast period; high growth in this segment can be attributed to the advantages of bioinformatics platforms, such as reduction in overall time for processing data, phylogenetic analysis, and identification of sequence similarity.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=39
Based on application, the market is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, molecular phylogenetics, and other applications (glycomics, cytomics, physiomics, and interactomics). The genomics segment is expected to account for the largest market share in 2016.. The increasing use of pharmacogenomics is a major factor contributing to the growth of this segment.
North America is expected to account for the largest share of the bioinformatics market in 2016. The increasing demand for bioinformatics across genomics and proteomics research, technological advancements, increasing research funding, and presence of a large number of market players and research institutes are driving the growth of the bioinformatics market in this region.
Download Sample Request: https://www.marketsandmarkets.com/requestsample.asp?id=39
Major players operating in the bioinformatics market include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and Agilent Technologies (U.S.).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com